Plaintiffs in the litigation report experiencing these specific digestive system complications: Gastroparesis (stomach paralysis): The most common injury alleged in lawsuits, this condition involves partial or complete paralysis of stomach muscles that prevents proper digestion and can persist even after discontinuing medication Ileus (intestinal blockage): Added to FDA warning labels in September 2023 after post-marketing reports, this condition stops intestinal movement and can lead to life-threatening complications including infection and tissue death Intestinal obstruction and pseudo-obstruction: Physical or functional blockages requiring emergency hospitalization and often surgical intervention to prevent bowel perforation Chronic severe symptoms: Persistent vomiting, uncontrollable nausea, dangerous dehydration requiring IV fluids, and electrolyte imbalances necessitating repeated emergency department visits The FDAs decision to update warning labels demonstrates growing concern about these complications
Variables included in the models were: type 2 diabetes, arterial hypertension, plasma levels of ALT, AST, HHT, triglycerides, HDL-C, HOMA-IR and alcohol consumption
It is a GLP-1 medication that has few contraindications and few side effects
8-10 Large-scale lifestyle intervention studies in breast cancer survivors have demonstrated weight loss in the range of 4% to 6%, but the effect on breast cancer outcomes remains unclear, which may be due at least in part to the difficulty of maintaining weight loss over time
A medical evaluation is the best way to compare options
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
